APA:
Copy. (2018). Paeonol ameliorates diabetic renal fibrosis through promoting the activation of the Nrf2/ARE pathway via up-regulating Sirt1. FRONTIERS IN PHARMACOLOGY, 9(-), 1-15. SID. https://sid.ir/paper/692374/en
Vancouver:
Copy. Paeonol ameliorates diabetic renal fibrosis through promoting the activation of the Nrf2/ARE pathway via up-regulating Sirt1. FRONTIERS IN PHARMACOLOGY[Internet]. 2018;9(-):1-15. Available from: https://sid.ir/paper/692374/en
IEEE:
Copy, “Paeonol ameliorates diabetic renal fibrosis through promoting the activation of the Nrf2/ARE pathway via up-regulating Sirt1,” FRONTIERS IN PHARMACOLOGY, vol. 9, no. -, pp. 1–15, 2018, [Online]. Available: https://sid.ir/paper/692374/en